Guardant Health, Inc. (GH) vs Illumina, Inc. (ILMN)
- Guardant Health, Inc. GH 158.29 −4.58%
- Illumina, Inc. ILMN 262.03 −2.20%
Guardant Health, Inc. and Illumina, Inc. are both Diagnostics & Research companies. Illumina, Inc. is the larger, with a market value of $40.5B against $22.3B — 1.8× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Illumina, Inc. trades at 48.4×. Guardant Health, Inc. grew revenue faster over the last twelve months: 42.7% against 4.88%. Illumina, Inc. has the higher net margin (18.4% vs −38.3%) and the higher return on invested capital (17.5% vs −129.7%). Across the 18 metrics below, Illumina, Inc. leads on 12 and Guardant Health, Inc. on 6.
Valuation
Profitability
| Metric | GH | ILMN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.01% | 66.39% | 50.89% |
| Operating margin | (39.75%) | 19.65% | (8.57%) |
| Net margin | (38.33%) | 18.36% | (6.37%) |
| Free cash flow margin | (20.35%) | 20.72% | 0.00% |
| Return on equity | 171.64% | 32.38% | (2.92%) |
| Return on assets | (27.95%) | 12.95% | (6.71%) |
| Return on invested capital | (129.70%) | 17.46% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack